These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31229178)

  • 1. D3 and D1 receptors: The Yin and Yang in the treatment of restless legs syndrome with dopaminergics.
    Clemens S; Ghorayeb I
    Adv Pharmacol; 2019; 84():79-100. PubMed ID: 31229178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D3 Receptors and Restless Legs Syndrome.
    Clemens S
    Curr Top Behav Neurosci; 2023; 60():229-249. PubMed ID: 35435646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D3 receptor agonist efficacy in restless legs syndrome.
    Casoni F; Galbiati A; Ferini-Strambi L
    Adv Pharmacol; 2019; 84():21-35. PubMed ID: 31229173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with dopamine D3 receptor agonists induces a behavioral switch that can be rescued by blocking the dopamine D1 receptor.
    Dinkins ML; Lallemand P; Clemens S
    Sleep Med; 2017 Dec; 40():47-52. PubMed ID: 29221778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Dopamine D1 and D3 Receptor Modulation and Expression in the Spinal Cord of Two Mouse Models of Restless Legs Syndrome.
    Meneely S; Dinkins ML; Kassai M; Lyu S; Liu Y; Lin CT; Brewer K; Li Y; Clemens S
    Front Behav Neurosci; 2018; 12():199. PubMed ID: 30233336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.
    Earley CJ; Uhl GR; Clemens S; Ferré S
    Sleep Med; 2017 Mar; 31():71-77. PubMed ID: 27539027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing aging-related shift of excitatory dopamine D1 and inhibitory D3 receptor protein expression in striatum and spinal cord.
    Keeler BE; Lallemand P; Patel MM; de Castro Brás LE; Clemens S
    J Neurophysiol; 2016 Jan; 115(1):363-9. PubMed ID: 26561599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?
    Paulus W; Schomburg ED
    Sleep Med Rev; 2006 Jun; 10(3):185-96. PubMed ID: 16762808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
    Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L
    Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
    Paulus W; Trenkwalder C
    Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out mice.
    Clemens S; Hochman S
    J Neurosci; 2004 Dec; 24(50):11337-45. PubMed ID: 15601940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat.
    Cruz-Trujillo R; Avalos-Fuentes A; Rangel-Barajas C; Paz-Bermúdez F; Sierra A; Escartín-Perez E; Aceves J; Erlij D; Florán B
    Neuropharmacology; 2013 Apr; 67():370-8. PubMed ID: 23238327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology of restless legs syndrome].
    Miyamoto M; Miyamoto T; Iwanami M; Suzuki K; Hirata K
    Brain Nerve; 2009 May; 61(5):523-32. PubMed ID: 19514512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased excitability of spinal pain reflexes and altered frequency-dependent modulation in the dopamine D3-receptor knockout mouse.
    Keeler BE; Baran CA; Brewer KL; Clemens S
    Exp Neurol; 2012 Dec; 238(2):273-83. PubMed ID: 22995602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.
    Frau R; Mosher LJ; Bini V; Pillolla G; Pes R; Saba P; Fanni S; Devoto P; Bortolato M
    Psychoneuroendocrinology; 2016 Jan; 63():59-67. PubMed ID: 26415119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
    Bogan RK
    Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D3 dopamine receptor directly interacts with D1 dopamine receptor in immortalized renal proximal tubule cells.
    Zeng C; Wang Z; Li H; Yu P; Zheng S; Wu L; Asico LD; Hopfer U; Eisner GM; Felder RA; Jose PA
    Hypertension; 2006 Mar; 47(3):573-9. PubMed ID: 16401764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the dopamine D3 receptor: an overview of drug design strategies.
    Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V
    Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole Responsive Neck Numbness: The Therapeutic Role of Dopamine Agonists in the Spinal Cord Indicating to a Common Spinal Pathophysiology with Restless Leg Syndrome (RLS)?
    Yulug B; Hanoglu L
    Curr Clin Pharmacol; 2016; 11(3):221-222. PubMed ID: 27450363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.